MNKD Competitors
MannKind Corporation
$3.16
+$0.11(+3.61%)
24
Overall
20
Value
18
Tech
34
Quality
Market Cap
$996.79M
Volume
1.69M
52W Range
$2.23 - $6.51
Target Price
$7.84
MNKD competitors: HALO, NVO, MRK, LLY, NKTR. MannKind Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
MNKD Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| HALO Halozyme Therapeutics, Inc. | $124.83 | $14.17B | $8.31 | - | 65 |
| NVO Novo Nordisk A/S | $39.06 | $172.95B | $3.42 | 4.75% | 50 |
| MRK Merck & Co., Inc. | $149.88 | $365.88B | $2.66 | 2.27% | 77 |
| LLY Eli Lilly and Company | $1270.75 | $1.20T | $33.56 | 0.53% | 68 |
| NKTR Nektar Therapeutics | $38.27 | $1.31B | $-8.08 | - | 29 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MNKD | $3.16 | +3.6% | 1.69M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |